OAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and nine...
OAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and six...
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates PR Newswire LEXINGTON, Mass., Nov. 14, 2022 - Pre-clinical results published in PLOS ONE...
LogicBio acquisition to build on current collaborations and advancements in genomic medicine Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.52 | -6.43564356436 | 8.08 | 8.21 | 7.41 | 234468 | 7.7969749 | CS |
4 | 1.14 | 17.7570093458 | 6.42 | 8.24 | 6.185 | 295903 | 7.24559147 | CS |
12 | 2.1 | 38.4615384615 | 5.46 | 8.24 | 5.12 | 288485 | 6.44393268 | CS |
26 | 1.99 | 35.7271095153 | 5.57 | 8.24 | 4.92 | 288807 | 5.9618215 | CS |
52 | 5.49 | 265.217391304 | 2.07 | 8.24 | 2.07 | 179062 | 5.86800864 | CS |
156 | 4.59 | 154.545454545 | 2.97 | 8.24 | 0.2573 | 251872 | 2.09486266 | CS |
260 | -0.64 | -7.80487804878 | 8.2 | 11.5966 | 0.2573 | 197244 | 3.09336799 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales